Validation of selected aspects of psychometry of the Polish version of the Multiple Sclerosis Impact Scale 29 (MSIS-29);Analiza walidacyjna wybranych aspektów psychometrycznych polskiej wersji Skali Wpływu Stwardnienia Rozsianego na Jakość Życia Chorych (MSIS-29)

Neurologia i Neurochirurgia Polska

Volumn 41, Issue 3, 2007, Pages 215-222

  Jamroz Wiśniewska, Anna ^a   Papuć, Ewa ^a   Bartosik Psujek, Halina ^a   Belniak, Ewa ^a   Mitosek Szewczyk, Krystyna ^a   Stelmasiak, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

MSIS 29; Multiple sclerosis; Validation

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CORRELATION ANALYSIS; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS IMPACT SCALE 29; PHYSICAL DISABILITY; POLAND; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; RELIABILITY; VALIDATION PROCESS;

ADULT; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLAND; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS;

EID: 34447627528     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Miller J.R. Stwardnienie rozsiane. W: Rowland L.P [red.]. Neurologia Merritta. Wyd. 1 pol., Urban & Partner, Wrocław 2004; ss. 775-794.
2. Hobart J., Lamping D., Fitzpatrick R. i wsp. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. Brain 2001; 124: 962-973.
3. McGuigan C., Hutchinson M. The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure. J Neurol Neurosurg Psychiatry 2004; 75: 266-269.
4. Hoogervorst E.L., Zwemmer J.N., Jelles B. i wsp. Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability. Mult Scler 2004; 10: 569-574.
5. Riazi A., Hobart J.C., Lamping D.L. i wsp. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of fife rating scales. Mult Scler 2003; 9: 411-419.
6. Riazi A., Hobart J.C., Lamping D.L. i wsp. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples. J Neurol Neurosurg Psychiatry 2002; 7: 701-704.
7. Hobart J.C., Riazi A., Lamping D.L. i wsp. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Health Technol Assess 2004; 8: 1-48.
8. Heffernan C., Jenkinson C. Measuring outcomes for neurological disorders: a review of disease-specific health status instruments for three degenerative neurological conditions. Chronic Illn 2005; 1: 131-142.
9. Kossakowska M. Standaryzacja polskiej wersji Kwestionariusza do Oceny Jakości Życia w Stwardnieniu Rozsianym (FAMS). Psychologia Jakości Zycia 2004, 3: 61-80.
10. McDonald W.I., Compston A., Edan G. i wsp. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
11. Rao S.M., Leo G.J., Bernardin L. i wsp. Cognitive dysfunction in multiple sclerosis. Frequency, patterns, and prediction. Neurology 1991; 41: 685-691.
12. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.
13. Jaracz K. Adaptacja kulturowa narzedzi badawczych do oceny jakości życia. W: Wołowicka L. [red.]. Jakość życia w naukach medycznych. Akademia Medyczna im. Karola Marcinkowskiego w Poznaniu, Poznań 2001; ss. 281-289.
14. Celia D.F., Dineen K., Arnason B. Validation of the functional assessment of multiple sclerosis quality of life instrument. Neurology 1996; 47: 129-139.
15. Arnett P.A., Randolph J.J. Longitudinal course of depression symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 2006; 77: 606-610.
16. Pittion-Vouyovitch S., Debouverie M., Guillemin F. i wsp. Fatigue in multiple sclerosis is related to disability, depression and quality of life. J Neurol Sci 2006; 243: 39-45.
17. Moran P.J., Mohr D.C. The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis. J Behav Med 2005; 28: 35-41.
18. Krupp L.B., LaRocca N.G., Muir-Nash J. i wsp. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-1123.
19. Amato M.P., Ponziani G., Rossi F. i wsp. Quality of life in multiple sclerosis: the impact of depression, fatigue and disability. Mult Scler 2001; 7: 340-344.
20. Janardhan V., Bakshi R. Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. J Neurol Sci 2002; 205: 51-58.
21. De Stefano N., Battaglini M., Stromillo M.L. i wsp. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006; 129: 2008-2016.
22. Brzeziński J. Trafność i rzetelnośćd testów psychologicznych. Wyd. 1. Gdańskie Wydawnictwo Psychologiczne, Sopot 2005.